JACOBS LEVY EQUITY MANAGEMENT, INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$2,219,072
+273.2%
2,264,359
+429.3%
0.01%
+333.3%
Q2 2023$594,631
+140.5%
427,792
+175.1%
0.00%
+50.0%
Q1 2023$247,250
-72.8%
155,503
+6.5%
0.00%
-66.7%
Q4 2022$909,699
-0.3%
146,019
+316.3%
0.01%
-25.0%
Q4 2020$912,000
-29.8%
35,072
+0.3%
0.01%
-38.5%
Q3 2020$1,299,000
-34.5%
34,952
-9.5%
0.01%
-38.1%
Q2 2020$1,982,000
+64.8%
38,620
+1.2%
0.02%
+40.0%
Q1 2020$1,203,000
-51.1%
38,159
-7.5%
0.02%
-37.5%
Q4 2019$2,460,000
+107.8%
41,247
+27.7%
0.02%
+60.0%
Q3 2019$1,184,000
-18.0%
32,310
+4.1%
0.02%
-25.0%
Q2 2019$1,444,000
+13.3%
31,050
-2.1%
0.02%
+11.1%
Q1 2019$1,274,000
+239.7%
31,720
+289.2%
0.02%
+157.1%
Q4 2018$375,000
+7.8%
8,150
+3.8%
0.01%
+40.0%
Q3 2018$348,000
+11.2%
7,850
-57.6%
0.01%
-28.6%
Q1 2016$313,00018,5000.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders